**Executive Summary**
This addendum, issued by the National Pharmaceutical Pricing Authority (NPPA) on July 8, 2026, amends Order No. 1584(E) dated March 25, 2026. The document updates the ceiling price fixation schedule for Ringer Lactate (non-Glass with special features) by adding a specific manufacturer and product line. The primary action is to align the pricing of the newly added products with specific existing formulation price standards.
**Key Points / Main Content**
**Amendments to Table ‘B’**
* **New Entry:** M/s Sachin Parenteral Pvt. Ltd. is added to Table ‘B’ at Serial Number 31.
* **Product Identification:** The amendment specifically applies to the brands "Euro Head / Safe Port."
**Pricing Specifications (Clause e1)**
* **Applicable Pricing:** For the products listed under M/s Sachin Parenteral Pvt. Ltd., the ceiling price is restricted to the formulation price specified at Serial Number 4 of Table ‘A’ of the original order.
* **Regulatory Scope:** This applies specifically to scheduled formulation packs of Ringer Lactate in non-Glass containers with special features.
**Impact Analysis**
**M/s Sachin Parenteral Pvt. Ltd.**
**Impact**
The company’s products (Euro Head / Safe Port) are now formally included in the price control schedule for Ringer Lactate (non-Glass with special features). Their pricing is now capped according to the specific rates mentioned in Table A of the primary order.
**Action Required**
The manufacturer must ensure that the pricing for Euro Head and Safe Port formulations does not exceed the ceiling price specified at Serial Number 4 of Table A in the original March 2026 order.
**Pharmaceutical Distributors and Retailers**
**Impact**
Supply chain stakeholders are affected by the regulated price limits imposed on the "Euro Head / Safe Port" brands produced by M/s Sachin Parenteral Pvt. Ltd.
**Action Required**
Update inventory and billing systems to reflect the applicable ceiling price for these specific products to ensure compliance with the NPPA directive.
Key Entities Referenced
National Pharmaceutical Pricing Authority (NPPA): The regulatory body under the Ministry of Chemicals and Fertilizers responsible for fixing and regulating the ceiling prices of scheduled drug formulations.
Ringer Lactate (non-Glass with special features): The specific scheduled pharmaceutical formulation pack whose ceiling price fixation is the primary subject of this regulatory notification.
Order No. 1584(E): The original pharmaceutical pricing order dated 25th March 2026, which this notification amends to include additional manufacturer details.
M/s Sachin Parenteral Pvt. Ltd.: The manufacturing company added to the regulatory schedule for the ceiling price applicability of its Ringer Lactate product 'Euro Head / Safe Port'.
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
सी.जी.-डी.एल.-अ.-09072026-274325
CG-DxLx-xEG-I0D9H0x7x2x0 26-274325
xxxGIDExxx
असाधारण
EXTRAORDINARY
भाग II—खण् ड 3—उप-खण्ड (ii)
PART II—Section 3—Sub-section (ii)
प्राजधकार स ेप्रकाजित
PUBLISHED BY AUTHORITY
स.ं 3552] नई दिल्ली, बुधर्ार, िुलाई 8, 2026/आषाढ 17, 1948
No. 3552] NEW DELHI, WEDNESDAY, JULY 8, 2026/ASHADHA 17, 1948
रसायन और उर्रव क मत्रं ालय
(औषध जर्भाग)
(राष्ट्रीय औषध मल्ू य जनधारव ण प्राजधकरण)
पररजिष्ट
नई दिल्ली, 8 िुलाई, 2026
का.आ. 3714(अ).— भारत के असाधारण, रािपत्र म ेंप्रकाजित, राष्ट्रीय औषध मूल्य जनधावरण प्राजधकरण के आिेि
संख्या 1584 (अ) दिनांक 25 मार् व 2026 िो दक ररंगर लक्ै टेट (जर्िेष सुजर्धाओं के साथ नॉन-ग्लास) के अनुसूजर्त
फॉर्मयुवलेिन पक्ै स के अजधकतम मूल्य जनधारव ण स े संबंजधत ह ैको अब स ेजनम्नजलजखत िोडकर पढा िाय:े
(1) क्र. संख्या 31 को सारणी 'ख' म ेंजनम्नानुसार िोडा िाएगा:
क्र.स ं जर्जनमातव ाओं का नाम उत्पाि/ब्ाडं का नाम
(1) (2) (3)
31. मेसस व सजर्न पैरेंरल प्राइर्ेट जलजमटेड (नीर्े नोट ड1) यूरो हडे / सेफ़ पोर्ट
5151 GI/2026 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
(2) खडं (ड1) के बाि िोडा गया ह ैऔर इस ेइस प्रकार पढा िाएगा:
“(ड1) सारणी 'ख' की क्रमांक संख्या 31 म ें उजल्लजखत मेससव सजर्न पैरेंरल प्राइर्ेट जलजमटेड के मामले म,े सारणी ‘क’ की
केर्ल क्रमांक संख्या 4 में जनर्िष्टव फॉमूवलिे न की कीमतें लाग ू होती ह।ैं
[का.सं./280/148/2026/एफ़ / फा. स. ं 8(148)/2026/डीपी/एनपीपीए-जडर्ी-II]
भीर्ा राम यािर्, सहायक जनििे क
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ADDENDUM
New Delhi, the 8th July, 2026
S.O. 3714(E).— The National Pharmaceutical Pricing Authority’s Order No. 1584(E) dated 25th March 2026,
published in the Gazette of India, Extraordinary, related to ceiling price fixation of scheduled formulation packs of
Ringer Lactate (non-Glass with special features) is henceforth to be read with the following additions:
(1) Sl. No. 31 shall be added in Table ‘B’ as below:
Sl. No. Name of Manufacturer Product/ Brand Name
(1) (2) (3)
31. M/s Sachin Parenteral Pvt. Ltd. (note e1 below) Euro Head / Safe Port
(2) Clause (e1) is added after clause (e) & shall be read as follows:
“(e1) In case of M/s Sachin Parenteral Pvt. Ltd. mentioned in Sl. No. 31 of Table B, only the price of the formulation
specified at Sl. No. 4 of Table A is applicable”.
[PN/280/148/2026/F / F. No. 8(148)/2026/D.P./NPPA-Div.-II]
BHIVA RAM YADAV, Assistant Director
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.